↓ Skip to main content

Dove Medical Press

Article Metrics

Pharmacologic agents for smoking cessation: A clinical review

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, November 2013
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#38 of 110)
  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
4 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
62 Mendeley
Title
Pharmacologic agents for smoking cessation: A clinical review
Published in
Clinical Pharmacology : Advances and Applications, November 2013
DOI 10.2147/cpaa.s8788
Pubmed ID
Authors

Dilip R Patel, Cynthia Feucht, Lesley Reid, Neil D Patel

Abstract

Tobacco use has been clearly demonstrated to have negative health consequences. Smoking cigarettes is the predominant method of tobacco use. The tar contained within cigarettes and other similar products is also harmful. Other tarless tobacco containing products do exist but carry no significantly decreased risk. While nicotine is considered to be principally responsible for tobacco addiction, other chemicals in the cigarette smoke including acetaldehyde may contribute to the addictive properties of tobacco products. The adverse health consequences of tobacco use have been well documented. Studies have shown that a combined behavioral and pharmacological approach is more effective in smoking cessation than either approach alone. Pharmacotherapy can achieve 50% reduction in smoking. With pharmacotherapy the estimated 6-month abstinence rate is about 20%, whereas it is about 10% without pharmacotherapy. The first-line of drugs for smoking cessation are varenicline, bupropion sustained release, and nicotine replacement drugs, which are approved for use in adults. Data are insufficient to recommend their use in adolescents. This article reviews the use of pharmacological agents used for smoking cessation. A brief overview of epidemiology, chemistry, and adverse health effects of smoking is provided.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
United States 1 2%
Unknown 60 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 18%
Researcher 8 13%
Student > Bachelor 7 11%
Professor > Associate Professor 7 11%
Student > Ph. D. Student 4 6%
Other 17 27%
Unknown 8 13%
Readers by discipline Count As %
Medicine and Dentistry 24 39%
Agricultural and Biological Sciences 9 15%
Nursing and Health Professions 5 8%
Environmental Science 3 5%
Social Sciences 3 5%
Other 6 10%
Unknown 12 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 December 2015.
All research outputs
#6,373,949
of 12,159,304 outputs
Outputs from Clinical Pharmacology : Advances and Applications
#38
of 110 outputs
Outputs of similar age
#76,985
of 204,096 outputs
Outputs of similar age from Clinical Pharmacology : Advances and Applications
#4
of 11 outputs
Altmetric has tracked 12,159,304 research outputs across all sources so far. This one is in the 47th percentile – i.e., 47% of other outputs scored the same or lower than it.
So far Altmetric has tracked 110 research outputs from this source. They receive a mean Attention Score of 2.9. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,096 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.